Ian Tebbett Ph.D.
Academic Qualifications: Professor Tebbett has a bachelor’s degree in Pharmacy and a Ph.D. degree in Forensic Toxicology. He has previously held faculty positions with the Forensic Science programs at the University of Strathclyde, Scotland and the University of Illinois at Chicago (1988-92). Dr. Tebbett is the director of the UF Forensic Sciences and Pharmaceutical Chemistry Programs and a professor in the University of Florida colleges of Pharmacy and Veterinary Medicine. Dr. Tebbett previously served as director of Analytical Toxicology and director of the Racing Laboratory in the UF College of Veterinary Medicine. He has worked as a consultant for many international and national law enforcement agencies and has testified in Florida, Illinois and Europe. His research interests include, novel approaches to education and training in forensic science; the passage of drugs and metabolites across the blood/ brain barrier and the placental barrier, and the subsequent distribution, metabolism and elimination of these drugs; development of novel extraction and analytical techniques; FTIR, solid phase extraction, column switching techniques and supercritical fluid extraction and chromatography for the examination of drugs; and investigation of the relationship between drug abuse and immune suppression.
Donna Wielbo, Ph.D.
Academic Qualifications: Professor Wielbo received a master’s degree in forensic science, and was employed by the British Home Office Forensic Science Service before earning a Ph.D. from the University of Illinois. Currently, Dr. Wielbo is an associate professor in the department of Medicinal Chemistry at the University of Florida College of Pharmacy and the program coordinator for all Forensic related programs. Dr. Wielbo is also the academic advisor for the online MS degree programs in Forensic Serology and DNA, and Forensic Science. As an assistant professor in the College of Pharmacy, Dr. Wielbo conducted research in the area of hypertension and molecular biology. After conducting genomics research with Curagen corporation, she then worked for the National Forensic Science Technology Center in the area of training and education.
Oliver Grundmann, Ph.D.
Academic Qualifications: Oliver Grundmann received a bachelor’s degree in Pharmacy and European pharmacist license from the University of Muenster, Germany, in 2004 and started his Ph.D. at the University of Florida shortly thereafter. While continuing his Ph.D. in Pharmaceutical Sciences, he worked for the Forensic Science program after graduating with a master’s degree in Forensic Toxicology and minor in Statistics. His research interests include the search for new treatment options from natural products for CNS diseases such as anxiety disorders and depression as well as structural elucidation and mechanism of action of new drug entities derived from natural products and natural poisons. He also is interested in the implementation and impact of national and international collaborations for curricular development in the natural sciences. Currently, Dr. Grundmann is a Clinical Associate Professor with the Department of Medicinal Chemistry, College of Pharmacy and the Department of Adult and Elderly Nursing, College of Nursing at the University of Florida. He develops and teaches courses for the Distance Education program and is director of the pharmaceutical science program with a concentration in pharmaceutical chemistry. In addition, he holds an adjunct assistant professor position with the Pharmaceutical Science department, College of Pharmacy at Midwestern University. Link to faculty website: http://plaza.ufl.edu/grundman/
Margaret James, Ph.D.
Academic Qualifications: Professor James received her Ph.D. and her DSc degrees from the University of London. She is currently the Jack C. Massey Professor of Pharmacy and Chair of the department of Medicinal Chemistry and a professor of pharmacology at the University of Florida. Dr. James has technical experience in enzymology; analytical and protein chemistry; in vivo/in vitro correlations; the use of fish models for intestinal bioavailability studies, and the use of rat models for drug metabolism studies. Her research interests include factors affecting the metabolism and toxicity of drugs and other xenobiotics in humans and animal species, including aquatic species; drug and xenobiotic biotransformation; mechanistic toxicology; and intestinal bioavailability of xenobiotics; Dr. James has a dynamic and productive, federally funded, research laboratory. Dr. James is also a consultant in the areas of drug metabolism, animal models and toxicology related to metabolism.